 | Up a level |
Kempf, Christoph; Stucki, Martin; Boschetti, Nicola (2007). Pathogen inactivation and removal procedures used in the production of intravenous immunoglobulins. Biologicals, 35(1), pp. 35-42. London: Elsevier 10.1016/j.biologicals.2006.01.002
Millward, Thomas A; Heitzmann, Markus; Bill, Kurt; Längle, Ulrich; Schumacher, Peter; Forrer, Kurt (2008). Effect of constant and variable domain glycosylation on pharmacokinetics of therapeutic antibodies in mice. Biologicals, 36(1), pp. 41-7. London: Elsevier 10.1016/j.biologicals.2007.05.003
Schegg, Vanessa; Vogel, Monique; Didichenko, Svetlana; Stadler, Michael B; Beleznay, Zsuzsanna; Gadola, Stephan; Sengupta, Christine; Stadler, Beda M; Miescher, Sylvia M (2008). Evidence that anti-muscarinic antibodies in Sjögren's syndrome recognise both M3R and M1R. Biologicals, 36(4), pp. 213-22. London: Elsevier 10.1016/j.biologicals.2007.11.001
Stucki, Martin; Boschetti, Nicola; Schäfer, Wolfram; Hostettler, Thomas; Käsermann, Fabian; Nowak, Thomas; Gröner, Albrecht; Kempf, Christoph (2008). Investigations of prion and virus safety of a new liquid IVIG product. Biologicals, 36(4), pp. 239-247. London: Elsevier 10.1016/j.biologicals.2008.01.004
Peterhans, Ernst; Schweizer, Matthias (2013). BVDV: a pestivirus inducing tolerance of the innate immune response. Biologicals, 41(1), pp. 39-51. Elsevier 10.1016/j.biologicals.2012.07.006
Behrensdorf-Nicol, Heike A; Bonifas, Ursula; Isbrucker, Richard; Ottiger, Hanspeter; Tierney, Robert; Hanschmann, Kay-Martin; Weisser, Karin; Krämer, Beate (2014). Results of an international transferability study of the BINACLE (binding and cleavage) assay for in vitro detection of tetanus toxicity. Biologicals, 42(4), pp. 199-204. Elsevier 10.1016/j.biologicals.2014.05.001
